Editorial & Opinion
أعرض في EDS

SARS-CoV-2 vaccination in patients with GI and hepatobiliary carcinoma: a call for booster vaccination.

التفاصيل البيبلوغرافية
العنوان: SARS-CoV-2 vaccination in patients with GI and hepatobiliary carcinoma: a call for booster vaccination.
المؤلفون: Monin MB; Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany malte_benedikt.monin@ukbonn.de.; German Centre for Infection Research (DZIF), Partner-site Cologne-Bonn, Bonn, Germany., Baier L; Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany., Berger M; Institute for Medical Biometry, Informatics and Epidemiology, University Hospital Bonn, Bonn, Germany., Gorny JG; Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany., Zhou T; Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany., Mahn R; Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany., Sadeghlar F; Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany., Möhring C; Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany., van Bremen K; Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany.; German Centre for Infection Research (DZIF), Partner-site Cologne-Bonn, Bonn, Germany., Boesecke C; Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany.; German Centre for Infection Research (DZIF), Partner-site Cologne-Bonn, Bonn, Germany., Rockstroh J; Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany.; German Centre for Infection Research (DZIF), Partner-site Cologne-Bonn, Bonn, Germany., Strassburg C; Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany., Eis-Hübinger AM; Institute of Virology, University Hospital Bonn, Bonn, Germany., Gonzalez-Carmona MA; Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany.
المصدر: Gut [Gut] 2023 Jun; Vol. 72 (6), pp. 1227-1229. Date of Electronic Publication: 2022 Jul 26.
نوع المنشور: Letter; Comment
اللغة: English
بيانات الدورية: Publisher: British Medical Assn Country of Publication: England NLM ID: 2985108R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-3288 (Electronic) Linking ISSN: 00175749 NLM ISO Abbreviation: Gut Subsets: MEDLINE
أسماء مطبوعة: Original Publication: London, British Medical Assn.
مواضيع طبية MeSH: COVID-19 Vaccines* , COVID-19*/prevention & control, Humans ; SARS-CoV-2 ; Vaccination ; Antibodies, Viral
مستخلص: Competing Interests: Competing interests: CB received honoraria for lectures and/ or consultancies from AbbVie, Gilead, Janssen, MSD, ViiV and funding from Dt. Leberstiftung, DZIF, Hector Stiftung, NEAT ID. MAG-C has contributed to advisory boards for Roche, Eisai, BMS, MSD and AZ. MBM received travel expenses and honoraria from Gilead and Virology Education. GJR received travel expenses and honoraria from Gilead. JR has received honoraria for lectures and/or consultancies from Abivax, Galapagos, Gilead, Merck, Janssen, Theratechnologies and ViiV. However, these activities have no potential conflicts of interest with the manuscript.
التعليقات: Comment on: Gut. 2020 Aug;69(8):1369-1372. (PMID: 32499304)
فهرسة مساهمة: Keywords: CHOLANGIOCARCINOMA; COVID-19; HEPATOBILIARY CANCER; HEPATOCELLULAR CARCINOMA; IMMUNE RESPONSE
المشرفين على المادة: 0 (COVID-19 Vaccines)
0 (Antibodies, Viral)
تواريخ الأحداث: Date Created: 20220726 Date Completed: 20230508 Latest Revision: 20230508
رمز التحديث: 20240628
DOI: 10.1136/gutjnl-2022-328169
PMID: 35882561
قاعدة البيانات: MEDLINE
الوصف
تدمد:1468-3288
DOI:10.1136/gutjnl-2022-328169